 |
인쇄하기
취소
|
ViroMed to go global
ViroMed Co. plans to enter into a technology transfer or licensing transaction with respect to VM202, one of the plasmid-based therapeutics for the prevention and treatment of cardiovascular disease.
In the recently held “Korea Bio Biz Day 2008” hosted by the Korea Trade-Investment Promotion Agency (KOTRA), ViroMed officials will have an opportunity to contact eight multinational companies ...
In the recently held “Korea Bio Biz Day 2008” hosted by the Korea Trade-Investment Promotion Agency (KOTRA), ViroMed officials will have an opportunity to contact eight multinational companies ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.